Identification of effective anti-osteosarcoma agents via screening of an in-house NQO1-targeted compound library
- 18 March 2025
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 122, 118162
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Novel NQO1 substrates bearing two nitrogen redox centers: Design, synthesis, molecular dynamics simulations, and antitumor evaluationBioorganic Chemistry, 2023
- Osteosarcoma: A comprehensive review of management and treatment strategiesAnnals of Diagnostic Pathology, 2020
- Retrospective review of the activity and safety of apatinib and anlotinib in patients with advanced osteosarcoma and soft tissue sarcomaInvestigational New Drugs, 2020
- Discovery of quinone-directed antitumor agents selectively bioactivated by NQO1 over CPR with improved safety profileEuropean Journal of Medicinal Chemistry, 2017
- Novel naphtho[2,1-d]oxazole-4,5-diones as NQO1 substrates with improved aqueous solubility: Design, synthesis, and in vivo antitumor evaluationBioorganic & Medicinal Chemistry, 2016
- 2-Substituted 3-methylnaphtho[1,2-b]furan-4,5-diones as novel L-shaped ortho-quinone substrates for NAD(P)H:quinone oxidoreductase (NQO1)European Journal of Medicinal Chemistry, 2014
- Proton‐based radiotherapy for unresectable or incompletely resected osteosarcomaCancer, 2011
- Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer DevelopmentCell, 2011
- Osteosarcoma treatment: state of the artCancer and Metastasis Reviews, 2009
- Inhibition of Poly(ADP-ribose) Polymerase Activation Attenuates β-Lapachone-Induced Necrotic Cell Death in Human Osteosarcoma CellsToxicology and Applied Pharmacology, 2002